Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$3.34 0.6%
Market Cap
$266.5M
Price Target
Refer to Report
Volume
88.9K
52wk Range
$1.16 - $6.83
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.